CVX vs EBS · P/E 17, rev $189.03B vs rev $1.04B
Chevron Corp (CVX) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CVX revenue for 2025-12-31 was $189.03B. Net income was $12.30B. Revenue was down 6.8% from 2024-12-31 to 2025-12-31. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CVX and EBS stock pages for the full models.
Not investment advice.